Works matching IS 21534888 AND DT 2020 AND VI 11 AND IP 3
Results: 24
First-in-Class Oral MK-6482 Shows Exciting Results in Clear-Cell Renal-Cell Carcinoma.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 3, p. 26
- By:
- Publication type:
- Article
Sitravatinib, Novel TKI, plus Nivolumab Elicits Good Responses in Renal-Cell Carcinoma.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 3, p. 25
- By:
- Publication type:
- Article
Universal CAR T-Cells a Promising Off-the-Shelf Therapy for T-Cell ALL.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 3, p. 24
- By:
- Publication type:
- Article
International Society of Cannabis Pharmacists Plans to Hold Inaugural Meeting in 2020.
- Published in:
- 2020
- By:
- Publication type:
- Interview
Adding 2 Immunotherapies to Cabozantinib Extends Survival in Advanced Liver Cancer.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 3, p. 21
- Publication type:
- Article
Promising 3-Drug Regimen for Advanced Gastric Cancer, Regardless of PD-L1 Expression.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 3, p. 21
- By:
- Publication type:
- Article
Atezolizumab-Bevacizumab Combo Improves Survival and Quality of Life in Unresectable Liver Cancer.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 3, p. 20
- By:
- Publication type:
- Article
Pemazyre (Pemigatinib) First Targeted Therapy FDA Approved for Cholangiocarcinoma with FGFR2 Biomarker.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 3, p. 18
- By:
- Publication type:
- Article
Androgen-Deprivation Therapy Seldom Used with Radiation in Localized Prostate Cancer.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 3, p. 17
- By:
- Publication type:
- Article
Jelmyto First FDA-Approved Therapy for Low-Grade Upper-Tract Urothelial Cancer.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 3, p. 17
- Publication type:
- Article
Pemazyre First FDAApproved Therapy for Cholangiocarcinoma plus FGFR2 Fusion.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 3, p. 16
- Publication type:
- Article
Immune Checkpoint Inhibitor Does Not Improve Outcomes in Metastatic Prostate Cancer.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 3, p. 16
- By:
- Publication type:
- Article
Tabrecta First FDA-Approved Targeted Therapy for Metastatic NSCLC and METExon 14 Skipping.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 3, p. 14
- Publication type:
- Article
Cancer Research During and After COVID-19.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 3, p. 14
- Publication type:
- Article
More Genetic Testing Needed in Breast Cancer.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 3, p. 12
- By:
- Publication type:
- Article
Capecitabine Improves Outcomes in TNBC When Added to Other Systemic Therapy.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 3, p. 12
- By:
- Publication type:
- Article
Retevmo First Therapy Approved for 3 Types of Cancers with RET Mutations.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 3, p. 9
- Publication type:
- Article
Two Ways to Target Tumors with KRAS Mutations.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 3, p. 8
- By:
- Publication type:
- Article
Atezolizumab, Vemurafenib, and Cobimetinib Triplet Therapy Improves PFS in BRAF-Positive Melanoma.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 3, p. 8
- By:
- Publication type:
- Article
Bispecific CAR T-Cells Show Promise in Children and Young Adults with Relapsed B-Cell ALL.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 3, p. 7
- By:
- Publication type:
- Article
I-SPY 2: Durvalumab plus Olaparib and Paclitaxel Triplet in High-Risk Breast Cancer "Graduates" to Phase 3 Study.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 3, p. 1
- By:
- Publication type:
- Article
Early Detection of Cancer Feasible with Blood-Based Tests.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 3, p. 1
- By:
- Publication type:
- Article
Impact of COVID-19 on Telehealth.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 3, p. 1
- By:
- Publication type:
- Article
Why Is COVID-19 More Aggressive in Certain Patients with Cancer?
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 3, p. 1
- By:
- Publication type:
- Article